Sign In
Buy WAT
$357.20
-1.05 (-0.293%)
At Close: Jun 23, 2026
Waters (WAT) Down 8.4% Since Last Earnings Report: Can It Rebound?
12:31pm, Wednesday, 11'th Mar 2026
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
08:00am, Monday, 09'th Mar 2026
News Summary: Reduces standard testing times by 80%.1 Delivers an industry-leading 25,000 data points per second, detecting transient material behaviors previously invisible to measurement. 2 Operates
Waters (WAT) Upgraded to Buy: What Does It Mean for the Stock?
01:00pm, Thursday, 05'th Mar 2026
Waters (WAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Waters Corporation (WAT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
02:17pm, Monday, 02'nd Mar 2026
Waters Corporation (WAT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Artisan Partners Limited Partnership Sells 34,925 Shares of Waters Corporation $WAT
04:24am, Saturday, 28'th Feb 2026
Artisan Partners Limited Partnership decreased its position in shares of Waters Corporation (NYSE: WAT) by 9.0% in the third quarter, according to its most recent Form 13F filing with the Securities a
Waters (WAT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
10:55am, Friday, 27'th Feb 2026
After losing some value lately, a hammer chart pattern has been formed for Waters (WAT), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions
Andra AP fonden Purchases 105,995 Shares of Waters Corporation $WAT
03:14am, Friday, 27'th Feb 2026
Andra AP fonden grew its holdings in shares of Waters Corporation (NYSE: WAT) by 1,044.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission.
Waters Corporation to Present at the TD Cowen Health Care Conference
04:45pm, Monday, 23'rd Feb 2026
MILFORD, Mass., Feb. 23, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Headlines: Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput bioseparations, DMPK, and 'omics application
What Moved Markets This Week
06:41am, Saturday, 14'th Feb 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
02:15pm, Friday, 13'th Feb 2026
WAT tops Q4 estimates as revenues rise 7% Y/Y, with strong Pharma and Europe growth, and upbeat 2026 sales and earnings outlook.
Down 19.0% in 4 Weeks, Here's Why Waters (WAT) Looks Ripe for a Turnaround
10:35am, Friday, 13'th Feb 2026
Waters (WAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates cou
Envestnet Asset Management Inc. Reduces Holdings in Waters Corporation $WAT
05:17am, Thursday, 12'th Feb 2026
Envestnet Asset Management Inc. lowered its position in Waters Corporation (NYSE: WAT) by 11.6% during the undefined quarter, according to the company in its most recent disclosure with the Securities
BD Merges Biosciences & Diagnostics Business With Waters
02:35pm, Wednesday, 11'th Feb 2026
BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.
Waters Corp (WAT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions
04:01pm, Monday, 09'th Feb 2026
Revenue Growth: 7% reported growth and 6% constant currency growth for Q4 2025.Adjusted EPS: Increased by low double digits to $4.53 for Q4 2025.GAAP EPS: $3.7
